mercedesman wrote: theinvestor22 wrote: I can't say you're being overly optimistic. There would appear to be a lot of potential future apprecation tied up in those as yet un-IPOed companies. Hopefully, that will get unlocked over time.
SolexxX wrote: What's you best guess on Q1 earnings? My guess is >= $0.02/share. Just a guessing. Am I being too optimistic? I don't have much concrete evidence to base this on.
sounds like more "hurry up and wait"from the newly appointed, and resident Mgt apologist.
I agree that investors, by and large, are an impatient lot. But many here, including myself, have been very patient.
I see future potential for sure, but what of already realized gains ? That's a drum that could & should be beaten.
Out of favour sector you say? Nope !
Gains in the general cannabis sector were outsized from Sept 2020 to Feb 2021. QCA barely budged during that time period.
the bottom line is that the stock has been trading with a market cap ranging from 40% to 60% of its NAV
for going on two years now.
At first I told myself that's because Cannibis was dormant until the US market woke up. Well the industry woke up ( anticipation of and actual Dem win in 2020) yet QCA remained in nap mode.
That suggests a lack of awareness, a lack of promotion and for some reason, a lack of demand for undervalued assets.
If the SAFE Act goes in Cannabis' favour state-side, what's to prevent the same lack of awareness about what QCA does?
talking about the future potential of underlying IPOs doesn't cut it when when a large discount to underlying value ( TODAY!) is allowed to persist.
that's not arm-chair quarterbacking ...its calling out Mgt who's job it is to help remedy a market awareness shortfall ( not just acquire shares at cheap prices and seemingly shrug "oh well just wait until future Qtrs")
MM